Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition-Reference-Cited by-同舟云学术

Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition

Published:2021-10 Issue: Volume:350 Page:133-142
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Savira Feby^ORCID,Magaye Ruth,Scullino Carmen V.^ORCID,Flynn Bernard L.,Pitson Stuart M.,Anderson Dovile,Creek Darren J.,Hua Yue,Xiong Xin,Huang Li,Liew Danny,Reid Christopher^ORCID,Kaye David,Kompa Andrew R.,Wang Bing Hui^ORCID

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference48 articles.

1. Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate;Ahmed;BMC Nephrol.,2013

2. The uremic toxin acrolein promotes suicidal erythrocyte death;Ahmed;Kidney Blood Press. Res.,2013

3. Nrf2 signaling pathway: pivotal roles in inflammation;Ahmed;Biochim. Biophys. Acta Mol. Basis Dis.,2017

4. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: cross-talk among cytokines, Mg2+, NF-κB, and de novo ceramide;Altura;Am. J. Physiol. Heart Circ. Physiol.,2012

5. Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy;Andersen;J. Surg. Res.,2012

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fumonisin distorts the cellular membrane lipid profile: A mechanistic insight;Toxicology;2024-08

2. Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients;Frontiers in Physiology;2023-12-18

3. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens;Ecotoxicology and Environmental Safety;2023-12

4. The therapeutic potential of sphingolipids for cardiovascular diseases;Frontiers in Cardiovascular Medicine;2023-08-07

5. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease;Journal of Cardiovascular Development and Disease;2022-12-02